Veterans Mental Illness Research Publications - 2017 | NW MIRECC - MIRECC / CoE
Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

MIRECC / CoE

Menu
Menu

Quick Links

Veterans Crisis Line Badge
My healthevet badge
EBenefits Badge
 

Veterans Mental Illness Research Publications - 2017 | NW MIRECC

2017 NW MIRECC Staff Publications and Presentations

The following is a sampling of publications and presentations from 2017 by VISN 20 NW MIRECC researchers and fellowship program faculty. Where available, a link to the full article is provided at the end of the summary. For a sampling of additional articles, please see 2019, 2018, 2016, 2015, and 2014.

Demidenko, M. I., Dobscha, S. K., Morasco, B. J., Meath, T. H. A., Ilgen, M. A., & Lovejoy, T. I. (2017). Suicidal ideation and suicidal self-directed violence following clinician-initiated prescription opioid discontinuation among long-term opioid users. General Hospital Psychiatry, 47, 29-35.
Little is known about patient outcomes following discontinuation of opioid therapy, which may include suicidal ideation and suicidal self-directed violence. Five hundred-nine Veterans Health Administration (VHA) patients whose clinicians discontinued them from LTOT were selected from a national cohort of Veterans Health Administration (VHA) patients who discontinued opioids in 2012. The purpose of this study was to examine correlates of suicidal ideation and non-fatal suicidal self-directed violence in a sample of patients discontinued from long-term opioid therapy. Read full research: Suicidal ideation and suicidal self-directed violence following clinician-initiated prescription opioid discontinuation among long-term opioid users

Frank, J. W., Lovejoy, T. I., Becker, W. C., Morasco, B. J., Koenig, C. J., Hoffecker, L., ... Krebs, E. E. (2017). Patient outcomes in dose reduction or discontinuation of long-term opioid therapy A systematic review. Annals of Internal Medicine, 167(3), 181-191.
Expert guidelines recommend reducing or discontinuing long-term opioid therapy (LTOT) when risks outweigh benefits, but evidence on the effect of dose reduction on patient outcomes has not been systematically reviewed. The purpose of this study is to synthesize studies of the effectiveness of strategies to reduce or discontinue LTOT and patient outcomes after dose reduction among adults prescribed LTOT for chronic pain. Read full research article: Patient outcomes in dose reduction or discontinuation of long-term opioid therapy A systematic review

Lovejoy, T. I., Morasco, B. J., Demidenko, M. I., Meath, T. H. A., Frank, J. W., & Dobscha, S. K. (2017). Reasons for discontinuation of long-term opioid therapy in patients with and without substance use disorders. Pain (03043959), 158(3), 526-534.
Several factors may accelerate opioid discontinuation rates, including lack of information about the long-term effectiveness of opioids for chronic pain, heightened awareness about opioid-related adverse events, closer monitoring of patients for opioid-related aberrant behaviors, and greater restrictions around opioid prescribing. Rates of discontinuation may be most pronounced in patients deemed to be at "high risk." The purpose of this study was to compare reasons for discontinuation of long-term opioid therapy between patients with and without Substance Use Disorder diagnoses. This retrospective cohort study assembled a cohort of Veterans Health Administration patients prescribed opioid therapy for at least 12 consecutive months... Read full research article: Reasons for discontinuation of long-term opioid therapy in patients with and without substance use disorders

Lovejoy, T., Demidenko, M., Morasco, B., Meath, T., & Dobscha, S. (2017). (242) Suicidal ideation and behaviors following clinician-initiated prescription opioid discontinuation among long-term opioid users. Journal of Pain, 18, S36.
Rates of clinician-initiated discontinuation of long-term opioid therapy (LTOT) for chronic pain are increasing, particularly for patients who may be considered "complex" given significant medical, mental health, and substance use disorder comorbidities. Although it is unclear if opioid therapy discontinuation leads to exacerbation of pain... Read full research article: Suicidal ideation and behaviors following clinician-initiated prescription opioid discontinuation among long-term opioid users

Morasco, B. J., Yarborough, B. J., Smith, N. X., Dobscha, S. K., Deyo, R. A., Perrin, N. A., & Green, C. A. (2017). Higher prescription opioid dose is associated with worse patient-reported pain outcomes and more health care utilization. Journal of Pain, 18(4), 437-445.
Some previous research has examined pain-related variables on the basis of prescription opioid dose, but data from studies involving patient-reported outcomes have been limited. This study examined the relationships between prescription opioid dose and self-reported pain intensity, function, quality of life, and mental health. Read full research article: Higher prescription opioid dose is associated with worse patient-reported pain outcomes and more health care utilization

Nugent, S., Dobscha, S., Morasco, B., Demidenko, M., Meath, T., Frank, J., ... Lovejoy, T. I. (2017). Substance Use Disorder treatment following clinician-initiated discontinuation of long-term opioid therapy resulting from an aberrant urine drug test. JGIM: Journal of General Internal Medicine, 32(10), 1076-1082.
OBJECTIVE: To describe the proportion of patients who were referred to, and engaged in, substance use disorder (SUD) treatment following long-term opioid therapy (LTOT) discontinuation and to examine differences in substance use disorder (SUD) treatment referral and engagement based on the substances that led to discontinuation. Read full research article: Substance Use Disorder treatment following clinician-initiated discontinuation of long-term opioid therapy resulting from an aberrant urine drug test

Nugent, S. M., Morasco, B. J., O'Neil, M. E., Freeman, M., Low, A., Kondo, K., ... Kansagara, D. (2017). The effects of cannabis among adults with chronic pain and an overview of general harms: A systematic review. Annals of Internal Medicine, 167(5), 319-331.
Cannabis is increasingly available for the treatment of chronic pain, yet its efficacy remains uncertain. The purpose of this study is To review the benefits of plant-based cannabis preparations for treating chronic pain in adults and the harms of cannabis use in chronic pain and general adult populations. Read full research article: The effects of cannabis among adults with chronic pain and an overview of general harms: A systematic review

O’Neil, M. E., Nugent, S. M., Morasco, B. J., Freeman, M., Low, A., Kondo, K., ... Kansagara, D. (2017). Benefits and harms of plant-based cannabis for posttraumatic stress disorder: A systematic review. Annals of Internal Medicine, 167(5), 332-340.
Cannabis is available from medical dispensaries for treating posttraumatic stress disorder (PTSD) in many states of the union, yet its efficacy in treating PTSD symptoms remains uncertain. The purpose of this study is to identify ongoing studies and review existing evidence regarding the benefits and harms of plant-based cannabis preparations in treating PTSD in adults. Read full research article: Benefits and harms of plant-based cannabis for posttraumatic stress disorder: A systematic review


For additional articles, please see: 2019 | 2018 | 2017 | 2016 | 2015 | 2014